Article
Comparison of whole genome sequencing with clinical targeted panel sequencing of metastatic prostate cancer: insights from real-world data
2026-07-25
Abstract excerpt
<title>Abstract</title> We evaluated the clinical utility of Target-Enhanced Whole Genome Sequencing (TE-WGS) in comparison with targeted panel sequencing (TPS) for identifying clinically relevant genomic alterations in advanced prostate cancer. We applied TE-WGS to tumor/normal paired samples from patients with advanced prostate cancer previously tested with TPS during routine care. We compared the sensitivity of...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 34902d00-822f-5be8-b25e-bf8eff19309f
- DOI
- 10.1038/s41698-026-01602-y
